Skip to main content

. 1991 Apr;54(4):372–373. doi: 10.1136/jnnp.54.4.372

Subcutaneous apomorphine for parkinsonian patients with psychiatric side effects on oral treatment.

K Ray-Chaudhuri, R J Abbott, P A Millac

PMCID: PMC488501 PMID: 2056329

372

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

Chaudhuri K. R., Critchley P., Abbott R. J., Pye I. F., Millac P. A. Subcutaneous apomorphine for on-off oscillations in Parkinson's disease. Lancet. 1988 Nov 26;2(8622):1260–1260. doi: 10.1016/s0140-6736(88)90860-4. [DOI] [PubMed] [Google Scholar]
Horowski R. Psychiatric side-effects of high-dose lisuride therapy in parkinsonism. Lancet. 1986 Aug 30;2(8505):510–510. doi: 10.1016/s0140-6736(86)90374-0. [DOI] [PubMed] [Google Scholar]
Stibe C. M., Lees A. J., Kempster P. A., Stern G. M. Subcutaneous apomorphine in parkinsonian on-off oscillations. Lancet. 1988 Feb 20;1(8582):403–406. doi: 10.1016/s0140-6736(88)91193-2. [DOI] [PubMed] [Google Scholar]

ACTIONS

RESOURCES